Credit Suisse Group restated their underperform rating on shares of Humanigen (NASDAQ:HGEN – Get Rating) in a report issued on Monday morning, Benzinga reports. The firm currently has a $0.50 price objective on the stock. Separately, Cantor Fitzgerald initiated coverage on Humanigen in a research report on Wednesday, January 11th. They set a neutral rating […]